Last reviewed · How we verify

NCT05917054

Comparison of Bipolar Vascular Sealing and Conventional Back-table Dissection

Completed Last updated 23 June 2023
What this trial tests

trial testing use of bipolar vascular sealing method on the renal allograft at the back-table stage in Drain Site Complication in 98 participants. Completed in 1 January 2023.

Timeline
1 January 2021
Primary endpoint
31 December 2022
1 January 2023

Quick facts

Lead sponsorIstinye University
StatusCompleted
Study typeOBSERVATIONAL
Enrollment98
Start date1 January 2021
Primary completion31 December 2022
Estimated completion1 January 2023
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Istinye University

Who can join

18 and older, any sex, with Drain Site Complication. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The usage of vessel sealing devices has been gaining popularity in all surgical specialties. Post-renal transplant drain placement is a common practice among transplant surgeons. However, prolonged drainage accompanied by surgical wound complications and perirenal fluid collections is a frequent complication experienced by the recipients. This study aimed to compare bipolar sealing with conventional back-table dissection in terms of post-renal transplant drainage duration, amount, surgical wound complication, and back-table preparation time.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Drain Site Complication

Currently open trials in the same condition.

Other Istinye University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05917054.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing